MEZAVANT

This brand name is authorized in Australia, Austria, Canada, Cyprus, Estonia, Germany, Hong Kong SAR China, Ireland, Malta, Netherlands, Poland, Singapore, South Africa, Spain, UK.

Active ingredients

The drug MEZAVANT contains one active pharmaceutical ingredient (API):

1	Mesalazine UNII 4Q81I59GXC - MESALAMINE
	Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon.
	Read more about Mesalazine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MEZAVANT XL Gastro-resistant, prolonged release tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07EC02	Mesalazine	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EC Aminosalicylic acid and similar agents
Discover more medicines within A07EC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9353G
CA	Health Products and Food Branch	02297558
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00679581, 05106140, 13862335, 14163585, 14163591, 14297280, 14349025, 14404646, 14441280, 15387789, 15387795, 16336908, 16336914, 16917723, 17448118
EE	Ravimiamet	1515732, 1515743
ES	Centro de información online de medicamentos de la AEMPS	70144
GB	Medicines & Healthcare Products Regulatory Agency	127808, 196165, 196964, 199695, 373688, 376891
HK	Department of Health Drug Office	64540
IE	Health Products Regulatory Authority	30136, 44010, 44018, 70142
MT	Medicines Authority	MA1464/00201
NL	Z-Index G-Standaard, PRK	86673
PL	Rejestru Produktów Leczniczych	100261306
SG	Health Sciences Authority	14999P
ZA	Health Products Regulatory Authority	45/11/0463